Work

Pharmacoeconomic Analysis of Micafungin (Mycamine) 100 mg and 150 mg Daily In the Treatment of Candidemia.

Year: 2009
Type: article
Study design: Observational Study
Abstract: We conducted a retrospective study to assess pharmacoeconomic outcomes of patients who received a daily dose of micafungin 100 mg or 150 mg to treat candidemia. The once-daily 100-mg dose resulted in clinical and mycological outcomes similar to those achieved with 150 mg daily and succeeded in reducing drug-acquisition costs for treating hospitalized patients with candidemia.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W1484505353
FWCI: 0.209
Cites: 7
Cited by: 6
Related to: 10